Welcome to

Our Event


It is widely recognized that cellular and gene therapies (also referred to as advanced cellular therapies) hold the potential to revolutionize health care for a variety of diseases. However, the limitations of current technologies, the complexity of manufacturing, safety, efficacy and reimbursement models and understanding regulatory requirements for cell-based and cell-derived products as therapies have led to only a few players making it to the commercial stages. The cell and gene therapy industry is yet to address certain gaps relating to these limitations that will facilitate clinical and commercial success of these therapies.

Key players all over the globe are also looking to tackle some crucial needs such as scalable manufacturing (upstream and downstream), robustness and efficiencies to make these advanced cellular therapies cost effective and safe.

Taking into consideration the above issues, the Bioprocessing of Advanced Cellular Therapies Congress took place on 2-3 June 2016 at the London Heathrow Marriott Hotel - UK and presented some of the recent developments, approaches and novel technologies for bioprocessing cellular therapies. The focus was on the engineering challenges faced in this field with respect to bioprocessing from early process development to manufacturing scales.
It aimed to support the delegates in successful translation of unique bioprocesses to robust, scaled manufacturing production for successful clinical translation. The two-day congress concluded with a summary into key aspects around regulatory requirements, business development and reimbursement insights.
 
Key sessions:
• Upstream process development for gene therapies
• Upstream process development for cell based therapies
• Downstream processing considerations
• Analytics - tackling measurement assurance for advanced cellular therapeutics
• Insights into Business Development and Reimbursement
• Regulatory perspectives

Key Speakers at the Conference:
Chris Mason, Professor Of Regenerative Medicine, University College Of London, UK
Otto-Wilhelm Merten, Head Of The Applied Vectorology And Innovation, Généthon, France
Bo Kara, Head Process Development, Advanced Therapy DeliveryGSK, UK
Anne Plant, Program Director For Biosciences, NIST, USA
Paula Marques Alves, Chief Executive Officer, IBET, Portugal
Steve OhDirector Stem Cell Bioprocessing, Bioprocessing Technology Institute, Singapore
John GrayVP, R&DAudentes, USA

Post Show Report  2016:

Click here to view post show report of Bioprocessing of Advanced Cellular Therapies Congress 2016


Awesome Image

0 DAY EVENT

0 SPEAKERS

0 TICKETS

0 Hours of Networking

Agenda

Full Name *
Email Id *

Company *
Job Title *

Country Code *
Phone Number *

Country *




Advisors



Our Speakers

Bo Kara
Bo Kara

Anne Plant
Anne Plant

Program Director<br>Biosciences NIST, USA

Dr Damian Marshall
Dr Damian Marshall

Head of Analytical Development CT catapult

Dr Marc-Olivier Baradez
Dr Marc-Olivier Baradez

Lead Scientist Analytical Development CT Catapult

Dr Robert J Thomas
Dr Robert J Thomas

Reader in Manufacturing for Cell Based Therapies; EPSRC Early Career Fellow Centre for Biological Engineering (CBE), Wolfson School of Mechanical and Manufacturing Engineering Loughborough University, UK

Dr. Ivan Wall
Dr. Ivan Wall

Senior Lecturer, Cell Therapy Bioprocessing, UCL, UK

Dr. Qasim Rafiq
Dr. Qasim Rafiq

Assistant Professor, Bioprocess engineering Aston Medical Research Institute, Aston University, UK

Dr. Sven Kili
Dr. Sven Kili

VP and Development Head, Gene Therapy division GSK, UK


Know All Speakers


Event Sponsors

Platinium

Diamond

Gold

Silver

Sponsors & Exhibitors

Official Logistics Partner


Become Sponsor Know All Sponsors


Media Partners


Supporting Association



Submit your Poster Presentation

Venue

Bioprocessing of Advanced Cellular Therapies Congress 2-3 June 2016, London - UK

 

London Heathrow Marriott Hotel
Bath Road,
Heathrow Airport Hayes UB3 5AN
United Kingdom

Please note we have a group rate because of the volume of booking this event will generate.  We are not an agency and will not call you or try to sell you hotel deals or any ancillary services.  We get the venue to provide a secure online portal. You are free to make any arrangements you wish, but anyone calling or emailing claiming to represent us (especially a company called Exhibitors Housing Service) or to undercut our prices should be treated with a large degree of suspicion.

The London Heathrow Marriott Hotel has well-designed guest rooms which are complemented by intuitive service and comfortable amenities. The hotel’s location, a half mile from Heathrow Airport, allows guests to rest easy and enjoy stress-free travel connections with the airport’s handy Hoppa Bus shuttle service. Just a short drive from Twickenham Stadium, our hotel puts guests near motorways and the Heathrow Express so London attractions are only minutes away. Soundproof guest rooms include plush bedding, 24-hour room service and premium movie channels along with in-room laptop safes and large work areas. Five on-site restaurants, an indoor pool and fully-equipped Leisure Club provide added comfort and relaxation. Boasting 8,719 square feet of innovative event space, professional event managers and catering staff our hotel sets the stage for successful business and social events. Whether travelling on holiday or for business, our hotel is an ideal destination.

 

Our block of rooms at the London Heathrow Marriott has now expired.  You may still be able to book accommodation at the London Heathrow Marriott by visiting their website directly - http://www.marriott.co.uk/hotels/travel/lhrhr-london-heathrow-marriott-hotel/ Alternatively, you can see a list of nearby hotels by clicking here.

For further information please contact:
  • Steve Hambrook | Conference Director
  • steve.h@mnmconferences.com

 

London Heathrow Marriot Hotel

Heathrow Marriot Hotel - London

London Heathrow Hotel 


View on Map
Image Gallery